All Stories

  1. Patient preferences in the treatment of hemophilia A: A latent class analysis

    Article • PLoS ONE, August 2021, PLOS

    Professor Axel C. Mühlbacher

  2. Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results"

    Article • PLoS ONE, February 2021, PLOS

    Professor Axel C. Mühlbacher

  3. A discrete choice experiment to investigate patient preferences for HIV testing programs in Bogotá, Colombia

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, October 2018, Taylor & Francis

    Professor Axel C. Mühlbacher

  4. A best–worst scaling in Colombian patients to rank the characteristics of HIV/AIDS treatment

    Article • Journal of Medical Economics, February 2018, Taylor & Francis

    Professor Axel C. Mühlbacher

  5. Zielkriterien der medikamentösen Therapie des Diabetes Typ II: Eine Analyse der Patientenperspektive mit Analytic Hierarchy Process und Best-Worst Scaling

    Article • Das Gesundheitswesen, April 2015, Thieme Publishing Group

    Professor Axel C. Mühlbacher

  6. Eigenschaften von integrierten Versorgungs­programmen und deren Einfluss auf den Patientennutzen: Ein Discrete-Choice Experiment für Versorgungsnetzwerke

    Article • Das Gesundheitswesen, July 2014, Thieme Publishing Group

    Professor Axel C. Mühlbacher

  7. An exponential representation of health state utility

    Article • The European Journal of Health Economics, February 2004, Springer Science + Business Media

    Professor Axel C. Mühlbacher

  8. An exponential representation of health state utility

    Article • The European Journal of Health Economics, December 2003, Springer Science + Business Media

    Professor Axel C. Mühlbacher

  9. VV1 RISK ADJUSTMENT AND REFERENCE POINTS

    Article • Value in Health, November 2003, Elsevier

    Professor Axel C. Mühlbacher